Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

32.30
-0.5100-1.55%
Post-market: 32.940.6400+1.98%18:51 EST
Volume:1.01M
Turnover:32.56M
Market Cap:1.98B
PE:-24.87
High:32.80
Open:32.63
Low:31.85
Close:32.81
52wk High:55.33
52wk Low:23.30
Shares:61.15M
Float Shares:59.26M
Volume Ratio:0.87
T/O Rate:1.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2987
EPS(LYR):-1.2987
ROE:-16.43%
ROA:-13.56%
PB:4.18
PE(LYR):-24.87

Loading ...

Is Twist’s New Endotoxin‑Controlled Plasmid DNA Offering Altering The Investment Case For TWST?

Simply Wall St.
·
Dec 05

Twist Bioscience Introduces New Plasmid DNA Preparation Products

MT Newswires Live
·
Dec 04

Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade

InvestorPlace
·
Dec 02

Director Jan Johannessen Reports Disposal of Twist Bioscience Common Shares

Reuters
·
Nov 21

Stock Track | Twist Bioscience Plummets 5.06% as New Manufacturing Risk Overshadows Ark Invest's Purchase

Stock Track
·
Nov 18

Stock Track | Twist Bioscience Plummets 5.06% on Manufacturing Scaling Risk Disclosure

Stock Track
·
Nov 18

Twist Bioscience Faces Scaling Challenges: Potential Impact on Future Demand and Financial Health

TIPRANKS
·
Nov 18

Cathie Wood Bets Big on This Peter Thiel-Backed Coinbase Rival as Bitcoin Crashes Below $91,000

Benzinga
·
Nov 18

Twist Bioscience Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 17

Stock Track | Twist Bioscience Plummets 5.10% Pre-Market After Barclays Cuts Target Price

Stock Track
·
Nov 17

Will MRD Express and Margin Gains Change the Growth Trajectory for Twist Bioscience (TWST)?

Simply Wall St.
·
Nov 16

Twist Bioscience Shares Slide to Lowest in Two Years Following 4Q Loss

Dow Jones
·
Nov 15

Twist Bioscience Down Nearly 11%, On Track for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Nov 15

Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses

Benzinga
·
Nov 15

Twist Bioscience Corporation publishes ESG report

Reuters
·
Nov 15

Stock Track | Twist Bioscience Plummets 19.53% as Q4 Earnings Miss and Cautious 2026 Outlook Rattle Investors

Stock Track
·
Nov 14

Stock Track | Twist Bioscience Plummets 19.53% on Q4 Earnings Miss and Cautious 2026 Guidance

Stock Track
·
Nov 14

Stock Track | Twist Bioscience Plunges 7.66% Pre-Market on Earnings Miss and Soft Guidance

Stock Track
·
Nov 14

Stock Track | Twist Bioscience Plunges 7.66% Pre-market on Q4 Earnings Miss and Cautious Guidance

Stock Track
·
Nov 14

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal 2026 Total Revenue Range $425M to $435M, vs. FactSet Est of $431.9M

MT Newswires Live
·
Nov 14